Tech Company Financing Transactions

CORE Biomedicine Funding Round

CORE Biomedicine, based in Allston, scored $21 million from Elikon Venture, UTokyo Innovation Platform and CD Capital.

Transaction Overview

Company Name
Announced On
7/28/2026
Transaction Type
Venture Equity
Amount
$21,000,000
Round
Series A
Proceeds Purpose
The company intends to use the funds to advance its lead programs through discovery and early clinical development.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
127 Western Ave
Allston, MA 02134
USA
Phone
Undisclosed
Email Address
Overview
At CORE Biomedicine, we are redefining precision oncology -- developing next-generation cancer therapeutics that go beyond genomic alterations to address the fundamental biological programs driving tumor survival and progression. Mission: CORE Biomedicine is a preclinical-stage oncology company dedicated to innovating precision medicine therapeutics by targeting core lineage-dependent pathways in cancer. Traditional genomics-centric approaches capture only part of what sustains tumors. We are committed to unlocking the deeper biology that governs cancer identity and therapy resistance -- and to translating those insights into life-changing medicines.
Profile
CORE Biomedicine LinkedIn Company Profile
Social Media
CORE Biomedicine Company Twitter Account
Company News
CORE Biomedicine News
Facebook
CORE Biomedicine on Facebook
YouTube
CORE Biomedicine on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Ping Zhu
  Ping Zhu LinkedIn Profile  Ping Zhu Twitter Account  Ping Zhu News  Ping Zhu on Facebook
Chief Medical Officer
Tarek Sahmoud
  Tarek Sahmoud LinkedIn Profile  Tarek Sahmoud Twitter Account  Tarek Sahmoud News  Tarek Sahmoud on Facebook
President
Guozhu Zheng
  Guozhu Zheng LinkedIn Profile  Guozhu Zheng Twitter Account  Guozhu Zheng News  Guozhu Zheng on Facebook
VP - Bus. Development
Douglas McMillin
  Douglas McMillin LinkedIn Profile  Douglas McMillin Twitter Account  Douglas McMillin News  Douglas McMillin on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/28/2026: FireAI venture capital transaction
Next: 7/28/2026: Ominimo venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to document tech company VC transactions. VC investment data records reported here come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary